XML 20 R7.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
May 30, 2025
May 31, 2024
Cash flows from operating activities    
Net income (loss) $ 18,285 $ (26,141)
Net loss from discontinued operations 0 (8,148)
Net income (loss) from continuing operations 18,285 (17,993)
Adjustments to reconcile net income (loss) from continuing operations to net cash provided by operating activities:    
Depreciation expense and amortization of intangible assets 43,010 50,335
Amortization of debt issuance costs 2,820 2,827
Share-based compensation expense 33,362 32,801
Impairment of goodwill 11,373 0
Loss on extinguishment or prepayment of debt 0 (1,117)
Deferred income taxes, net 1,122 (3,646)
Other (2,469) (2,772)
Changes in operating assets and liabilities:    
Accounts receivable (40,760) 7,406
Inventories (30,776) (2,321)
Other assets 13,741 (5,703)
Accounts payable and accrued expenses and other liabilities 133,908 84,626
Payment of acquisition-related contingent consideration 0 (29,000)
Net cash provided by operating activities from continuing operations 183,616 117,677
Net cash used for operating activities from discontinued operations (4,099) (28,336)
Net cash provided by operating activities 179,517 89,341
Cash flows from investing activities    
Capital expenditures and deposits on equipment (6,087) (13,629)
Proceeds from maturities of investment securities 27,485 31,870
Purchases of held-to-maturity investment securities (46,127) (19,503)
Purchases of non-marketable investments 0 (1,000)
Other (1,015) (1,264)
Net cash used for investing activities from continuing operations (25,744) (3,526)
Net cash provided by investing activities from discontinued operations 28,350 119,389
Net cash provided by investing activities 2,606 115,863
Cash flows from financing activities    
Proceeds from issuance of preferred shares, net of $8,818 paid issuance costs 191,182 0
Repayments of debt 0 (126,634)
Payment of acquisition-related contingent consideration 0 (21,000)
Payments to acquire ordinary shares (49,240) (17,991)
Payment of preferred share cash dividends (5,100) 0
Distribution to noncontrolling interest 0 (1,470)
Proceeds from issuance of ordinary shares 7,745 8,064
Other 0 (584)
Net cash provided by (used for) financing activities from continuing operations 144,587 (159,615)
Net cash used for financing activities from discontinued operations 0 (606)
Net cash provided by (used for) financing activities 144,587 (160,221)
Effect of changes in currency exchange rates 0 (1,256)
Net increase in cash, cash equivalents and restricted cash 326,710 43,727
Cash, cash equivalents and restricted cash at beginning of period 383,477 410,064
Cash, cash equivalents and restricted cash at end of period $ 710,187 $ 453,791